New oral drug trial offers hope for rare, Tough-to-Treat sarcomas

NCT ID NCT03016819

Recruiting now Disease control Sponsor: Advenchen Laboratories, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing an oral medication called anlotinib for people with advanced forms of soft tissue sarcoma that have spread or cannot be removed by surgery. The main goal is to see if the drug can shrink tumors or slow their growth compared to standard chemotherapy. The trial is currently open for adults with a rare type called alveolar soft part sarcoma.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Cancer Hospital
COMPLETED

Beijing, China
Columbia University Medical Center
WITHDRAWN

New York, New York, 10032, United States
Hospital de la Santa Creu i Sant Pau
COMPLETED

Barcelona, Spain
Istituto Nazionale dei Tumori
COMPLETED

Milan, Italy
MD Anderson Cancer Center
COMPLETED

Houston, Texas, 77030, United States
Mayo Clinic Arizona
COMPLETED

Phoenix, Arizona, 85054, United States
Mayo Clinic Jacksonville
COMPLETED

Jacksonville, Florida, 32224, United States
Mayo Clinic Rochester
COMPLETED

Rochester, Minnesota, 55905, United States
Northwestern University
COMPLETED

Chicago, Illinois, 60611, United States
Royal Marsden Hospital
NOT_YET_RECRUITING

London, SW3 6JJ, United Kingdom

Contact

Contact Email: •••••@•••••
Sarcoma Oncology Center
RECRUITING

Santa Monica, California, 90403, United States

Contact

Contact Email: •••••@•••••
Shanghai Sixth People's Hospital
COMPLETED

Shanghai, China
Stanford Medicine Cancer Institute
COMPLETED

Stanford, California, 94305, United States
Thomas Jefferson Hospital - Sidney Kimmel Cancer Center
COMPLETED

Philadelphia, Pennsylvania, 19107, United States
UW Medicine-Seattle Cancer Care Alliance
COMPLETED

Seattle, Washington, 98109, United States
University Campus Bio-Medico
COMPLETED

Rome, Italy
University of California Los Angeles
COMPLETED

Los Angeles, California, 90404, United States
University of Colorado Denver
COMPLETED

Aurora, Colorado, 80045, United States
University of Miami Sylvester Comprehensive Cancer Center
COMPLETED

Miami, Florida, 33136, United States
University of Michigan Comprehensive Cancer Center
COMPLETED

Ann Arbor, Michigan, 48109, United States
University of Palermo
COMPLETED

Palermo, Italy
University of Pittsburgh Medical Center
COMPLETED

Pittsburgh, Pennsylvania, 15219, United States
Vanderbilt University
COMPLETED

Nashville, Tennessee, 37203, United States
Washington University St. Louis
COMPLETED

St Louis, Missouri, 63130, United States

Conditions

Explore the condition pages connected to this study.

ALVEOLAR SOFT PART SARCOMA LEIOMYOSARCOMA SOFT TISSUE SARCOMA SYNOVIAL SARCOMA